Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00212134 · ClinicalTrials.gov registry record · NA
Infant Aphakia Treatment Study (IATS)
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
NCT00212134: Completed NA study, sponsored by Stanford University.
NCT00212134 is a NA study that has completed, run by Stanford University. The registered enrollment target is 114 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00212134, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
Study Summary
The primary purpose is to determine whether infants with a unilateral congenital cataract are more likely to develop better vision following cataract extraction surgery if they undergo primary implantation of an intraocular lens or if they are treated primarily with a contact lens. In addition, the study will compare the occurrence of postoperative complications and the degree of parental stress between the two treatments.
Interventions
- DEVICE Contact lens correction of aphakia
- DEVICE Intraocular lens implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2004-12 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00212134
The ClinicalTrials.gov registry entry for NCT00212134 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Contact lens correction of aphakia is the first listed.
NCT00212134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00212134 about?
NCT00212134 is a clinical study titled "Infant Aphakia Treatment Study (IATS)". The primary purpose is to determine whether infants with a unilateral congenital cataract are more likely to develop better vision following cataract extraction surgery if they undergo primary implantation of an intraocular lens or if they are treated primarily with a contact lens. In addition, the ...
What is the current status of trial NCT00212134?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2004-12. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT00212134?
The interventions under investigation include: Contact lens correction of aphakia (DEVICE), Intraocular lens implantation (DEVICE).
Who is sponsoring clinical trial NCT00212134?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.